Home Drug Codes C Codes C9094 · ENJAYMO
Updated July 1st, 2026

ENJAYMO C Code: C9094

Inj, sutimlimab-jome, 10 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Inj, sutimlimab-jome, 10 mg
HCPCS Added Date July 1, 2022
Manufacturer Bioverativ
Route of Administration Intravenous
Generic Status HCPCS Discontinued
Dosage Type Single-Dose
Dosage Form Injection, Solution, Concentrate

About ENJAYMO

Enjaymo is a medication aligned to the HCPCS C Code: C9094 for billing, pricing, and reimbursement purposes in the United States. This Hematology medication is administered via the intravenous route and manufactured by Bioverativ.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to C9094. Package detail is available to logged-in subscribers.

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

ENJAYMO CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Enjaymo (C9094) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9094. Wastage billing guide →

ENJAYMO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Cold Agglutinin Disease

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Enjaymo billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for ENJAYMO.
Are there any available Enjaymo patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for ENJAYMO.
Where can I find Enjaymo prescribing information?
ENJAYMO prescribing information can be found at the link below: Visit Here →
Where can I find Enjaymo side effect information?
Information regarding ENJAYMO's side effects can be found at MedlinePlus Visit Here →
Does billing ENJAYMO require JZ/JW wastage modifiers?
CMS does not include ENJAYMO (C9094) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9094. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.